EZH2 controls epicardial cell migration during heart development

Area of Science:

• Developmental Biology
• Epigenetics
• Cardiovascular Research

Background:

• Enhancer of zeste homolog 2 (EZH2) is a key epigenetic regulator involved in development, catalyzing H3K27me3.
• The specific role of EZH2 in epicardial development remained largely uncharacterized.

Purpose of the Study:

• To investigate the function of EZH2 in epicardial development and its underlying molecular mechanisms.
• To determine the impact of EZH2 on epicardial cell migration and heart formation.

Main Methods:

• Utilized genetic deletion models in mice to study EZH2 function in epicardial cells.
• Employed RNA sequencing to identify EZH2-regulated genes in the epicardium.
• Performed loss-of-function studies and mass spectrometry to validate molecular interactions and downstream effects.

Main Results:

• EZH2 is expressed in epicardial cells during human and mouse heart development.
• Epicardial deletion of EZH2 led to impaired cell migration, myocardial hypoplasia, defective coronary plexus development, and embryonic lethality.
• EZH2 was found to transcriptionally suppress tissue inhibitor of metalloproteinase 3 (TIMP3) expression in epicardial cells.
• Loss of EZH2 function resulted in TIMP3 upregulation, promoting extracellular matrix reconstruction.

Conclusions:

• EZH2 is essential for proper epicardial cell migration and overall heart development.
• EZH2 facilitates epicardial migration by repressing TIMP3 transcription, highlighting a novel regulatory pathway.
• This study elucidates a critical role for EZH2 in coordinating epicardial development and extracellular matrix dynamics.